Delivery Order SPE2DB22D3401-SPE2DB25FT6FS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dificidin 200 mg tablets (20-count packaging) valued at $12,276.81. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $7,286.92 to AmerisourceBergen Drug Corp for Dificidin 200 mg tablets (20-count packages) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The pharmaceutical product will be delivered to the same location, supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dificid 200 mg tablets (20-count units) with a contract ceiling value of $15,984.50. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,261.46 to AmerisourceBergen Drug Corp for DIFICIDIN 200 mg tablets (20-count packages) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DIFICID 200 mg tablets. The contract has a completion date of February 6, 2024 and a potential value of $3,631.01. This delivery order is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical, with a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 23, 2025, for the supply of Dificid 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract is valued at $11,195.28 and carries a firm fixed price with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The $29,209.26 contract has a period of performance through July 11, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
- This is a firm fixed-price delivery order for $11,859.53 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug DIFICID 200 MG TABLET 20S, with a performance period ending on February 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg DIFICID tablets. The $6,932.80 firm fixed-price contract has a completion date of September 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,754.35 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6FSDelivery Order
The Defense Logistics Agency awarded a $9,759.44 delivery order to AmerisourceBergen Drug Corp for Dificidin 200 mg tablets (20-count packages) on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's primary IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The award reflects the company's established capability to fulfill federal pharmaceutical procurement requirements through open competition, with performance centered at the company's Conshohocken, Pennsylvania facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 9/16/25 |